Literature DB >> 24413618

Why vitamin D in Alzheimer's disease? The hypothesis.

Duygu Gezen-Ak1, Selma Yılmazer1, Erdinç Dursun1.   

Abstract

Scientists have worked for over a century to uncover the basis of Alzheimer's disease (AD) with the ultimate goal of discovering a treatment. However, none of the approaches utilized have defined the exact cause of the disease or an ultimate treatment for AD. In this review, we aim to define the role of vitamin D in AD from a novel and fundamental perspective and attempt to answer the following question: Why should we seriously consider "simple" vitamin D as a "fundamental factor" in AD? To answer this question, we explain the protective effects of vitamin D in the central nervous system and how the action of vitamin D and AD-type pathology overlap. Furthermore, we suggest that the role of vitamin D in AD includes not only vitamin D deficiency and vitamin D-related genes but also the disruption of vitamin D metabolism and action. This suggestion is supported by evidence that the disruption of vitamin D pathways mimic amyloid pathology. We define the term "inefficient utilization of vitamin D" as any alteration in vitamin D-related genes, including receptors, the enzymes related to vitamin D metabolism or the transporters of vitamin D, and we discuss the potential correlation of vitamin D status with the vulnerability of neurons to aging and neurodegeneration. Finally, in addition to the current knowledge that defines AD, we suggest that AD could be the result of a long-term hormonal imbalance in which the critical hormone is vitamin D, a secosteroid that has long been misnamed.

Entities:  

Keywords:  25-MARRS; Alzheimer's disease; ERp57/1; VDR; amyloid-β; calcium homeostasis; haplotype; hormone imbalance; oxidative stress; vitamin D; vitamin D deficiency

Mesh:

Substances:

Year:  2014        PMID: 24413618     DOI: 10.3233/JAD-131970

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  33 in total

1.  Vitamin D deficiency might pose a greater risk for ApoEɛ4 non-carrier Alzheimer's disease patients.

Authors:  Erdinç Dursun; Merve Alaylıoğlu; Başar Bilgiç; Haşmet Hanağası; Ebba Lohmann; Irem L Atasoy; Esin Candaş; Ömür Selin Araz; Burak Önal; Hakan Gürvit; Selma Yılmazer; Duygu Gezen-Ak
Journal:  Neurol Sci       Date:  2016-06-29       Impact factor: 3.307

2.  Amyloid Beta 1-42 Alters the Expression of miRNAs in Cortical Neurons.

Authors:  Erdinç Dursun; Esin Candaş; Selma Yılmazer; Duygu Gezen-Ak
Journal:  J Mol Neurosci       Date:  2018-12-04       Impact factor: 3.444

3.  The Transcriptional Regulatory Properties of Amyloid Beta 1-42 may Include Regulation of Genes Related to Neurodegeneration.

Authors:  Duygu Gezen-Ak; İrem L Atasoy; Esin Candaş; Merve Alaylıoğlu; Erdinç Dursun
Journal:  Neuromolecular Med       Date:  2018-06-12       Impact factor: 3.843

4.  Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.

Authors:  Lirong Wang; Jian Ying; Peihao Fan; Elise A Weamer; Mary Ann A DeMichele-Sweet; Oscar L Lopez; Julia K Kofler; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-27       Impact factor: 4.105

5.  Three Doses of Vitamin D and Cognitive Outcomes in Older Women: A Double-Blind Randomized Controlled Trial.

Authors:  Monica Castle; Nancy Fiedler; Lilliana Claudia Pop; Stephen J Schneider; Yvette Schlussel; Deeptha Sukumar; Lihong Hao; Sue A Shapses
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-04-17       Impact factor: 6.053

6.  The Effect of Nutrients on Alzheimer's Disease Biomarkers: A Metabolomic Approach.

Authors:  Εfstathia G Kalli
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Impact of vitamin D receptor polymorphisms in centenarians.

Authors:  Cristina Gussago; Beatrice Arosio; Franca Rosa Guerini; Evelyn Ferri; Andrea Saul Costa; Martina Casati; Elisa Mariadele Bollini; Francesco Ronchetti; Elena Colombo; Giuseppina Bernardelli; Mario Clerici; Daniela Mari
Journal:  Endocrine       Date:  2016-03-08       Impact factor: 3.633

8.  Vitamin D intake is associated with dementia risk in the Washington Heights-Inwood Columbia Aging Project (WHICAP).

Authors:  Chen Zhao; Angeliki Tsapanou; Jennifer Manly; Nicole Schupf; Adam M Brickman; Yian Gu
Journal:  Alzheimers Dement       Date:  2020-09-13       Impact factor: 21.566

Review 9.  Vitamin D, reactive oxygen species and calcium signalling in ageing and disease.

Authors:  Michael J Berridge
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-05       Impact factor: 6.237

10.  Protein disulfide isomerase A3 might be involved in the regulation of 24-dehydrocholesterol reductase via vitamin D equilibrium in primary cortical neurons.

Authors:  Ulaş Yavuz; Merve Alaylıoğlu; Büşra Şengül; Spyridon N Karras; Duygu Gezen-Ak; Erdinç Dursun
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-08-02       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.